首页|Jinzhou Medical University Reports Findings in Personalized Medicine (Exploring new mechanisms in cancer molecular pathways and pathogenic cell transformation: PIP4K2A as a prognostic marker and therapeutic target in cutaneous malignant mel anoma)

Jinzhou Medical University Reports Findings in Personalized Medicine (Exploring new mechanisms in cancer molecular pathways and pathogenic cell transformation: PIP4K2A as a prognostic marker and therapeutic target in cutaneous malignant mel anoma)

扫码查看
原文链接
  • NETL
  • NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News – New research on Drugs and Therapies - Personalized Medicine is the subject of areport. According to news reporting or iginating from Liaoning, People’s Republic of China, by NewsRxcorrespondents, r esearch stated, “Cutaneous malignant melanoma is a very aggressive and metastati cform of skin cancer, typically linked with poor outcomes. Advances in genomic analysis have underscoredthe crucial role of T cells in tumor immunity.”

LiaoningPeople’s Republic of ChinaAs iaBiomarkersCancerCutaneous MelanomaCyborgsDiagnostics and ScreeningDrugs and TherapiesEmerging TechnologiesGeneticsHealth and MedicineImmun otherapyMachine LearningMelanomaOncologyPersonalized MedicinePersonali zed TherapyPrognostic MarkersRisk and Prevention

2024

Robotics & Machine Learning Daily News

Robotics & Machine Learning Daily News

ISSN：
年,卷(期)：2024.(Dec.3)